09 January 08 09 January 08
--A pea-sized gland, weighs 0.5 gm & measures 1cm,A pea-sized gland, weighs 0.5 gm & measures 1cm,
attached to the hypothalamus by a stalk attached to the hypothalamus by a stalk
- Two lobes: anteroir & posterior Two lobes: anteroir & posterior
- Anterior lobe (adenohypophysis) Anterior lobe (adenohypophysis)
--derived from Rathke’s pouchderived from Rathke’s pouch
--contains cells that contains cells that secretsecrete trophic hormonese trophic hormones that activate peripheral endocrine glands that activate peripheral endocrine glands
--hypothalamic releasing hormones are deliveredhypothalamic releasing hormones are delivered via a portal venous system
via a portal venous system
-- Posterior lobe (neurohypophysis)Posterior lobe (neurohypophysis)
-- derived from outpouching from floor of 3rdderived from outpouching from floor of 3rd
ventricle ventricle
-- has a separate blood supplyhas a separate blood supply
-- consists of modified glial cells & consists of modified glial cells & axonsaxons extending from the supraoptic &
extending from the supraoptic & paraventr
paraventricular nuclei in icular nuclei in the hypothalamusthe hypothalamus
-- neurons in the supraoptic & paraventricularneurons in the supraoptic & paraventricular
nuclei pr
nuclei produce oduce ADH ADH & & oxytocinoxytocin
-- ADH & oxytocin are stored in axon terminalsADH & oxytocin are stored in axon terminals in
in the the post. post. LobeLobe
THE ADENOHYPOPHYSIS THE ADENOHYPOPHYSIS
-- FFive ive celcell tyl types pes in in the the adeadenohnohypoypophyphysis sis byby immunostaining:
immunostaining:
1-1- Lactotrophs (Mammotrophs):Lactotrophs (Mammotrophs): Prolactin (Prl) -Prolactin (Prl) -acidophils.
acidophils. 2
2- Somatotrophs- Somatotrophs: growth hormone (GH) -: growth hormone (GH) -acidophils.
acidophils.
3-3- Corticotrophs:Corticotrophs: proopiomelanproopiomelanocortin ocortin (POMC)(POMC) precurs
precursor or for for adrenocoradrenocorticotropic hormoneticotropic hormone
(ACTH), melanocyte stimulating hormone (MSH), (ACTH), melanocyte stimulating hormone (MSH),
ββ
-endorphin, and-endorphin, andββ
-lipotropin - basophils.-lipotropin - basophils. 44-- ThyrotrophsThyrotrophs:: thyroid stimulating hormone (TSH)thyroid stimulating hormone (TSH) - basophils.
- basophils.
5-5- Gonadotrophs:Gonadotrophs: follicle stimulating hormonefollicle stimulating hormone (FSH) & luteinizing hormone (LH) -
(FSH) & luteinizing hormone (LH) - basophils.basophils. Hypothalamic Releasing Hypothalamic Releasing Hormone Hormone Corresponding Anterior Corresponding Anterior Pituitary Hormone(s) Pituitary Hormone(s) Gonadotropin Gonadotropin Releasing Hormone Releasing Hormone (GnRH) * (GnRH) * Luteinizing Hormone Luteinizing Hormone (LH) (LH) Follicular Stimulating Follicular Stimulating Hormone (FSH) Hormone (FSH) Growth Hormone Growth Hormone Releasing Hormone Releasing Hormone (GRH) * (GRH) * Growth Hormone (GH) Growth Hormone (GH) Corticotropin Corticotropin Releasing Hormone Releasing Hormone (CRH) * (CRH) * Adrenocorticotropic Adrenocorticotropic Hormone (ACTH) Hormone (ACTH) Thyrotropin Releasing Thyrotropin Releasing Hormone (TRH) * Hormone (TRH) * Thyroid Stimulating Thyroid Stimulating Hormone (TSH) Hormone (TSH) Dopamine **
Dopamine ** Prolactin (PRL)Prolactin (PRL) * stimulatory
* stimulatory ** inhibitory ** inhibitory
DISEASES OF THE ADENOHYPOPHYSIS DISEASES OF THE ADENOHYPOPHYSIS
--
⇑
⇑
function:function: HyperpituitarismHyperpituitarism--
⇓
⇓
function:function: HypopituitarismHypopituitarism--nonfunctional adenomanonfunctional adenoma
--inflammatory lesionsinflammatory lesions
--ischemic injuryischemic injury
--mass effectsmass effects
--enlargement of sella turcicaenlargement of sella turcica
--visual field defects visual field defects (classica(classically bitemporallly bitemporal hemianopsia)
hemianopsia)
--
⇑
⇑
intracranial pressureintracranial pressure--headache, blurrinheadache, blurring of g of visionvision
--nausea and vomitingnausea and vomiting
P w e t s
P w e t s 1 of 131 of 13
PITUITARY GLAND
CAUSES
CAUSES
OF HYPERPITUITARISMOF HYPERPITUITARISM 1 - Primary hypothalamic disorders (rare) 1 - Primary hypothalamic disorders (rare) 2 - Primary Pituitary Hyperplasia (rare) 2 - Primary Pituitary Hyperplasia (rare) 3 - Functioning carcinomas (extremely rare) 3 - Functioning carcinomas (extremely rare) 4 - Functioning Adenomas (MCC). Classified as: 4 - Functioning Adenomas (MCC). Classified as:1. Prolactinomas (Prl) 1. Prolactinomas (Prl)
2. Somatotroph (GH) adenomas 2. Somatotroph (GH) adenomas 3. Corticotroph (ACTH) adenomas 3. Corticotroph (ACTH) adenomas 4. Gonadotroph (FSH/LH) adenomas 4. Gonadotroph (FSH/LH) adenomas 5. Thyrotroph (TSH) adenomas 5. Thyrotroph (TSH) adenomas 6. Pleurihormonal adenomas (GH+Prl). 6. Pleurihormonal adenomas (GH+Prl). Monoclonal but Monoclonal but
polyhormonal, or mixed-cell adenomas. polyhormonal, or mixed-cell adenomas.
HYPERPROLACTINEMIA HYPERPROLACTINEMIA (amenorrhea-galactorrhea syndrome)
galactorrhea syndrome) The MC
The MC pituitary hyperfunction syndrome. Causedpituitary hyperfunction syndrome. Caused by
by::
1- Prolactinomas; 1- Prolactinomas;
--Prl secreting adenoma (sparsely granulated,Prl secreting adenoma (sparsely granulated, chromophobic)
chromophobic)
--F/M >1, peak incidence 20-30 yrs. of ageF/M >1, peak incidence 20-30 yrs. of age
--serum prolactin levelserum prolactin level
>>
300 ug/L is diagnostic300 ug/L is diagnostic--Rx: surgery Rx: surgery (transsphenoida(transsphenoidal)l) bromocripti
bromocriptine ne (dopamine receptor agonist)(dopamine receptor agonist) radiation
radiation
2- Hypothalamic diseases. Hypothalamus normally 2- Hypothalamic diseases. Hypothalamus normally
produces dopamine (Prl-inhibitory factor). produces dopamine (Prl-inhibitory factor).
--head trauma, etc.head trauma, etc.
--stalk effectstalk effect
3- Anti-dopaminergic drugs
3- Anti-dopaminergic drugs (phenothiazines(phenothiazines,, haloperidol)
haloperidol)
4- Estrogen therapy 4- Estrogen therapy 5- P
5- Primary rimary HypothyroidiHypothyroidism sm ((
⇑
⇑
TRHTRH⇒
⇒ ⇑
⇑
Prl)Prl) Signs & Symptoms:Signs & Symptoms:
-- women: galactorrhea, amenorrhea,women: galactorrhea, amenorrhea, infertility,
infertility,
⇓
⇓
libidolibido-- men:men:
⇓
⇓
libido, impotence & libido, impotence & rarelyrarely galactorrhea &galactorrhea & gynecomastia gynecomastia SOMA
SOMATOTROPH TOTROPH ADENOMASADENOMAS Acromegaly
Acromegaly;;
--adult onset excess growth hormone (GH)adult onset excess growth hormone (GH)
⇒
⇒
enlarge
enlargement of the skullment of the skull, facial bones, j, facial bones, jaw, aw, hands,hands, feet, soft tissues & organs.
feet, soft tissues & organs.
--diabetes, hypertension, muscle diabetes, hypertension, muscle weakness, arthritis,weakness, arthritis,
gonadal dysfunction,
gonadal dysfunction, cardiovascardiovascular diseasecular disease Gigantism
Gigantism;;
--GH excess occurs in children (before closure of GH excess occurs in children (before closure of
epiphyses). epiphyses).
--generalized increase in body sizegeneralized increase in body size
*
* MorphologyMorphology: : macroadenomamacroadenomas, s, composed composed of of densely or
densely or sparsely granulated “acidophilic” cells,sparsely granulated “acidophilic” cells, strongly positive for GH by
strongly positive for GH by immunostains.immunostains.
-- 30% elaborate both GH and Prl (a mixed cell30% elaborate both GH and Prl (a mixed cell
adenoma or
adenoma or a single cell-type pleurihormonala single cell-type pleurihormonal adenoma).
adenoma).
-- 40% express the gsp oncogene40% express the gsp oncogene
-- GH acts indirectly byGH acts indirectly by
⇑
⇑
hepatic secretion of hepatic secretion of insulin-like growth factor-1 (IGF-1)insulin-like growth factor-1 (IGF-1)
-- Diagnosis:Diagnosis:
--
⇑
⇑
serum GH & IGF-1serum GH & IGF-1-- serum prolactin may be serum prolactin may be elevatedelevated
-- glucose suppression testglucose suppression test
-- imaging scans (MRI better than CAT scan)imaging scans (MRI better than CAT scan)
-- Treatment:Treatment:
-- transsphenoidatranssphenoidal l surgery, octreotidesurgery, octreotide
acetate, radiation acetate, radiation
CORTICOTROPH ADENOMAS CORTICOTROPH ADENOMAS
- MC small basophilic microadenomas that secrete - MC small basophilic microadenomas that secrete
ACTH ACTH
Cushing’s disease Cushing’s disease
--
⇑
⇑
ACTHACTH⇒
⇒ ⇑
⇑
secretion of cortisol from the secretion of cortisol from the adrenaadrenallglands glands
-- moon face, buffalo hump, truncal obesity,moon face, buffalo hump, truncal obesity,
abdominal striae abdominal striae
--diabetes mellitus, hirsutism and amenorrhea (ACTHdiabetes mellitus, hirsutism and amenorrhea (ACTH
stimulates
stimulates androgen androgen secretion)secretion)
--increaincreased skin sed skin pigmentation (MSH is pigmentation (MSH is secreted withsecreted with
pituitary ACTH) pituitary ACTH)
--hypertension, muscle weaknesshypertension, muscle weakness
-- Diagnosis:Diagnosis:
--24 hr urine for free cortisol & 17-24 hr urine for free cortisol &
17-hydroxycorticosteroids hydroxycorticosteroids
--plasma ACTH levelplasma ACTH level
--dexamethasone suppression testdexamethasone suppression test
--MRI scanMRI scan
Dexamethasone Suppression Dexamethasone Suppression TTestest
Pathologic Entity
Pathologic Entity LowLow Dose Dose High High Dose Dose ACTH Secreting ACTH Secreting Pituitary Adenoma Pituitary Adenoma – – ++ Cortisol Secreting Cortisol Secreting Adrenocortical Adrenocortical Neoplasm Neoplasm – – –– ACTH Secreting ACTH Secreting Nonendocrine Nonendocrine Neoplasm Neoplasm – – ––
OTHER FUNCTIONING ADENOMAS OTHER FUNCTIONING ADENOMAS Gonadotroph adenomas:
Gonadotroph adenomas:
--majority produce FSH, some FSH & LH, rarely onlymajority produce FSH, some FSH & LH, rarely only LH
LH
--MC occur in middle-aged men & womenMC occur in middle-aged men & women
--usually are macroadenomasusually are macroadenomas
--symptoms MC related only to local mass effectssymptoms MC related only to local mass effects
--may cause amenorrhea or galactorrhea,may cause amenorrhea or galactorrhea,
⇓
⇓
libido inlibido in menmen
Thyrotroph adenomas Thyrotroph adenomas
--produce TSHproduce TSH
⇒
⇒
hyperthyroidismhyperthyroidismHYPOPITUITARISM HYPOPITUITARISM
••
Caused by either hypothalamic or pituitaryCaused by either hypothalamic or pituitary lesions:lesions:
••
HypothalamHypothalamic lesions ic lesions : craniop: craniopharyngiomharyngioma,a, gliomas &gliomas & teratomas; metastatic carcinoma,teratomas; metastatic carcinoma, infections
infections
••
PituiPituitary tary lesiolesions ns ::o
o MCCs are: nonsecretory adenomas, Sheehan’sMCCs are: nonsecretory adenomas, Sheehan’s
syndrome, radiation or surgical ablation (of syndrome, radiation or surgical ablation (of
≥≥
75% of the gland)75% of the gland)
o
o LCCs are: metastatic carcinoma, inflammatoryLCCs are: metastatic carcinoma, inflammatory
disorders
disorders, , infections, ginfections, genetic defects enetic defects (pit-1)(pit-1)
••
Effects:Effects:
--Isolated hormone deficiencieIsolated hormone deficiencies (e.g. GH s (e.g. GH or LH)or LH)
--Panhypopituitarism:Panhypopituitarism: in childrenin children
⇒
⇒
dwarfism &dwarfism &infantilism (retarded physical & sexual infantilism (retarded physical & sexual development) &
development) & in adultsin adults
⇒
⇒
hypogonadism,hypogonadism, hypothyroidisHYPOTHALAMIC
HYPOTHALAMIC (SUPRASELLAR) (SUPRASELLAR) NEOPLASMSNEOPLASMS 1- Craniopharyngioma (MC)
1- Craniopharyngioma (MC) 2- Gliomas
2- Gliomas
3- Germ cell tumors 3- Germ cell tumors
⇒
⇒
mass effectmass effect⇒
⇒
hypopituitarism &/orhypopituitarism &/or diabetes insipidus.diabetes insipidus. Craniopharyngioma: Craniopharyngioma:
--Accounts for 3- 5% of intracranial tumorsAccounts for 3- 5% of intracranial tumors
--MC in the 2nd & MC in the 2nd & 3rd decades3rd decades
--derived from vestigial remnants of Rathke’s pouchderived from vestigial remnants of Rathke’s pouch
--arise in hypothalamus, may encroach on opticarise in hypothalamus, may encroach on optic
chiasm chiasm
--benign, contain epithelial elements, often cysticbenign, contain epithelial elements, often cystic
with
with calcificaticalcificationon
--rupture of cystic tumorsrupture of cystic tumors
⇒
⇒
inflammatory reactioninflammatory reactionNON-SECRETORY ADENOMAS NON-SECRETORY ADENOMAS -
- 20% 20% of of pituitary pituitary adenomasadenomas
--MC in 4th decade of lifeMC in 4th decade of life
-
- May grMay grow to ow to a a large large size (macroadenomas = size (macroadenomas = >1>1 cm).
cm).
--
⇒
⇒
local mass effect (headache & visuallocal mass effect (headache & visual disturbancesdisturbances), ), and and panhypopituitarpanhypopituitarismism (hypogonadism, hypothyroidism & (hypogonadism, hypothyroidism & hypoadrenalism).
hypoadrenalism). Histologically:
Histologically:
--most consist of cmost consist of chromophobic chromophobic cells ells or intenselyor intensely
eosinophilic cells (oncocytomas) eosinophilic cells (oncocytomas)
--usually are sparsely granularusually are sparsely granular
--
often stain negative for hormones with
often stain negative for hormones with
immunostains
immunostains
SHEEHAN’S SYNDROME SHEEHAN’S SYNDROME =
= Post-parPost-partum ischemic necrtum ischemic necrosis of the anteriorosis of the anterior pituitary.
pituitary.
Precipitated by obstetric hemorrhage or shock Precipitated by obstetric hemorrhage or shock
⇒
⇒
destruction ofdestruction of
≥≥
75% of the gland.75% of the gland. Pedisposing factors:Pedisposing factors:
--Anterior pituitary doubles in size duringAnterior pituitary doubles in size during
pregnancy pregnancy
--low pressure portal system unable tolow pressure portal system unable to
⇑
⇑
bloodbloodsupply supply
--abrupt onset of hypotensionabrupt onset of hypotension
⇒
⇒
hypoperfusionhypoperfusion⇒
⇒
infarction. infarction. Morphology: Morphology:
Early: gland is swollen, soft & hemorrhagic. Early: gland is swollen, soft & hemorrhagic. Later: replaced by a shrunken fibrous scar. Later: replaced by a shrunken fibrous scar. Effects:
Effects:
Failure of lactation, amenorrhea, hypothyroidism, Failure of lactation, amenorrhea, hypothyroidism, hypoadrenalism & decreased skin pigmentation. hypoadrenalism & decreased skin pigmentation. Poster
Posterior lobe: usually is ior lobe: usually is not affectednot affected POSTERIOR PITUITARY SYNDROMES POSTERIOR PITUITARY SYNDROMES ADH Deficiency (Diabetes Insipidus): ADH Deficiency (Diabetes Insipidus):
--
⇓
⇓
ADHADH⇒
⇒
decreased reabsorption of free waterdecreased reabsorption of free water--urine of low specific gravity, with inability tourine of low specific gravity, with inability to
concentrate it concentrate it
--polyuria, polydypsia and hypernatremiapolyuria, polydypsia and hypernatremia
--caused by hycaused by hypothalamic or pothalamic or pituitary lepituitary lesions;sions;
idiopathic idiopathic
--corrected readily by ADH administration.corrected readily by ADH administration.
Inappropriate ADH Secretion (SIADH) Inappropriate ADH Secretion (SIADH)::
--
⇑
⇑
ADHADH⇒
⇒
excessive reabsorption of free waterexcessive reabsorption of free water--oliguria, urine of high oliguria, urine of high specific gravity, withspecific gravity, with
inability
inability to to dilute dilute it, it, and and hyponatremhyponatremiaia
--due to a compensatorydue to a compensatory
⇑
⇑
in ANPin ANP⇒
⇒
nonohypervolemia, no
hypervolemia, no
⇑
⇑
BP and no peripheral edemaBP and no peripheral edema
--neurologic dysfunction: most likely 2neurologic dysfunction: most likely 200toto
hyponatremia hyponatremia
--MCC is ectopic ADH secretion by a small cellMCC is ectopic ADH secretion by a small cell
carcinoma
carcinoma
of
of
the lungthe lung
--Rx: fluid Rx: fluid restrictirestrictionon
Embryology: Embryology:
--the thyroid develops from the primitive pharynxthe thyroid develops from the primitive pharynx THYROID GLAND
--the developing thyroid is attached to the base of the developing thyroid is attached to the base of the tongue by the
the tongue by the thyroglossathyroglossal ductl duct
--the thyroid descends in the midline & assumes itsthe thyroid descends in the midline & assumes its final position in the anterior neck below the larynx final position in the anterior neck below the larynx
--excessive descent gives rise to a substernalexcessive descent gives rise to a substernal thyroid & incomplete descent
thyroid & incomplete descent
⇒
⇒
ectopic thyroidectopic thyroid higher in the neck or tonguehigher in the neck or tongue
--persistencpersistence of e of remnants of the thyroglossal ductremnants of the thyroglossal duct can
can
⇒
⇒
thyroglossathyroglossal duct l duct cystcystHYPERTHYROIDISM HYPERTHYROIDISM
=
= a a hypermetabohypermetabolic lic state, caused state, caused by increasedby increased levels of circulating T3 & T4.
levels of circulating T3 & T4.
Effects: nervousness, warm moist skin, fine Effects: nervousness, warm moist skin, fine
tremors, palpitations, rapid pulse, exophthalmos, tremors, palpitations, rapid pulse, exophthalmos, weight loss, heat intolerance, muscle atrophy & weight loss, heat intolerance, muscle atrophy & weakness, osteoporosis
weakness, osteoporosis Most Common
Most Common Causes: Graves’ disease, toxicCauses: Graves’ disease, toxic multinodular goiter, toxic adenoma
multinodular goiter, toxic adenoma Less Common Causes:
Less Common Causes:
--thyroiditthyroiditis, struma is, struma ovarii, toxic carcinomaovarii, toxic carcinoma
- TSH-secr
TSH-secreting eting pituitary adenomapituitary adenoma
--overtreatment with thyroid hormone tabletsovertreatment with thyroid hormone tablets
(factitious
(factitious hyperthyroihyperthyroidism)dism) HYPOTHYROIDISM
HYPOTHYROIDISM =
= a hypometabolic a hypometabolic state causstate caused by deficieed by deficiency of T3ncy of T3 & T4.
& T4.
Cretinism
Cretinism (congenital (congenital hypothyroidihypothyroidism)sm)
--Clinical: Clinical: severe severe mental mental retardation; retardation; shortshort
stature
stature; coarse ; coarse facial features, protruding tonguefacial features, protruding tongue - Causes:
- Causes:
--Endemic - due to dietary iodine deficiencyEndemic - due to dietary iodine deficiency
--SporadicSporadic
--thyroid dysgenesisthyroid dysgenesis
--inherited defects in thyroid hormoneinherited defects in thyroid hormone synthesis
synthesis
--inherited peripheral tissue resistance toinherited peripheral tissue resistance to thyroid hormone
thyroid hormone Myxedema
Myxedema (hypothyroidi(hypothyroidism in sm in adults)adults)
-- fatigue, lethargy, slowed speech, mentalfatigue, lethargy, slowed speech, mental
sluggishness sluggishness
-- cold intolerance, weight gain, constipationcold intolerance, weight gain, constipation
--
⇓
⇓
sweating, bradycardiasweating, bradycardia-- accumulation accumulation of of ECM subsECM substancestances
(glycosaminoglycans) (glycosaminoglycans)
-- coarsening of facial features, nonpittingcoarsening of facial features, nonpitting
edema edema Causes: Causes:
-- MCC is MCC is Hashimoto’s thyroiditisHashimoto’s thyroiditis..
-- surgicasurgical ablation l ablation or radiationor radiation
-- iodine deficiencyiodine deficiency
-- drugs (e.g. propylthiouracil, lithium)drugs (e.g. propylthiouracil, lithium)
-- idiopathic primary idiopathic primary hypothyroidishypothyroidismm
-- hypothalamic hypothalamic & pituita& pituitary ry disordersdisorders
HASHIMOTO’S THYROIDITIS HASHIMOTO’S THYROIDITIS -
- MCC MCC of of hypothhypothyroidism yroidism in in areas areas where where iodineiodine intake is adequate
intake is adequate Clinically:
Clinically:
--seen predominately in middle-aged womenseen predominately in middle-aged women
--hypothyroidishypothyroidism with m with painless enlargempainless enlargement of ent of thethe
gland gland
--may have transient thyrotoxicosis early onmay have transient thyrotoxicosis early on
Physiologi
Physiologic Effects c Effects of of Thyroid Hormones Thyroid Hormones • • gluconeogenesis,gluconeogenesis, glycogenolysis, glycogenolysis,
lipolysis & ATPase’s lipolysis & ATPase’s
•
• basal metabolic rabasal metabolic rate &te &
heat heat
production production
•
• protein catabolismprotein catabolism •
--familial predispositifamilial predisposition, associated on, associated with HLA-DR3with HLA-DR3
or HLA-DR5 or HLA-DR5 Pathogenesis: Pathogenesis:
--defective function of defective function of thyroid-specthyroid-specific suppressorific suppressor
T cells
T cells
⇒
⇒
emergence of helper T cells reactiveemergence of helper T cells reactive with thyroid antigenswith thyroid antigens
--helper T cells stimulate B cells to secretehelper T cells stimulate B cells to secrete
antithyr
antithyroid oid antibodies, directed against: thyroidantibodies, directed against: thyroid peroxidase, TSH-receptors, iodine transporter, & peroxidase, TSH-receptors, iodine transporter, & thyroglobulin
thyroglobulin, , etc.etc.
--thyroid injury is mediated by complement thyroid injury is mediated by complement fixingfixing cytotoxic
cytotoxic
antibodies, ADCC & CD8+ cytotoxic cells antibodies, ADCC & CD8+ cytotoxic cells
GRA
GRAVES’ DIVES’ DISEASESEASE Clinical:
Clinical:
--MCC of hyperthyroidism, peak incidence 20-40MCC of hyperthyroidism, peak incidence 20-40
y/o y/o
--a disease of females (F/M 10:1), affects 1-2% of a disease of females (F/M 10:1), affects 1-2% of
women in US women in US
--hyperthyrhyperthyroidism, oidism, symmetrical thyroidsymmetrical thyroid
enlargement enlargement
--opthalmopathy and dermopathy opthalmopathy and dermopathy (pretibia(pretibiall
myxedema) myxedema)
--familial predisposition, associated with HLA-B8 &familial predisposition, associated with HLA-B8 &
HLA-DR3 HLA-DR3
--Laboratory values:Laboratory values:
⇑
⇑
T3 & T4,T3 & T4,⇓
⇓
TSH andTSH and⇑
⇑
radioactive iodine uptake radioactive iodine uptake Pathogenesis:
Pathogenesis:
--An abnormality in T-suppressor cellsAn abnormality in T-suppressor cells
⇒
⇒
T-helperT-helpercells that react to thyroid Ag’s
cells that react to thyroid Ag’s
⇒
⇒
elaboration of B-elaboration of B-cell clones capable ofcell clones capable of producing autoantibodiesproducing autoantibodies reactive with TSH receptors.
reactive with TSH receptors.
--IgG antibodies directed against TSH IgG antibodies directed against TSH receptorreceptors,s,
act as agonists
act as agonists
⇒
⇒ ⇑
⇑
thyroid hormone secretion.thyroid hormone secretion. -- The autoaThe autoantibodies ntibodies were were originally originally called called longlong acting thyroid stimulator (LATS), because the acting thyroid stimulator (LATS), because the peak secretion of thyroid hormone occurs 16 peak secretion of thyroid hormone occurs 16 hours after the exposure of thyroid tissue to hours after the exposure of thyroid tissue to antibody, compare
antibody, compared with 2 hod with 2 hours for TSH.urs for TSH.
Therapy:
Therapy:
ββ
-blockers, propylthiouracil, potassium-blockers, propylthiouracil, potassium iodide, radioiodine ablation, surgeryiodide, radioiodine ablation, surgery
GOITER GOITER
= enlargement of the thyroid, MC
= enlargement of the thyroid, MC manifestation of manifestation of thyroid disease
thyroid disease
--
⇓
⇓
hormone synthesishormone synthesis⇒
⇒ ⇑
⇑
TSHTSH⇒
⇒
hyperplasia &hyperplasia & hypertrophy of follicular cellshypertrophy of follicular cells
⇒
⇒
gross enlargementgross enlargement Diffuse nontoxic goiter:Diffuse nontoxic goiter:
--endemicendemic
--iodine deficiencyiodine deficiency
--goitrogens (e.g. cabbage, goitrogens (e.g. cabbage, cauliflower,cauliflower, turnips, cassava root)
turnips, cassava root)
--sporadicsporadic
--goitrogensgoitrogens
--hereditary defect in thyroid hormonehereditary defect in thyroid hormone synthesis
synthesis
--Clinical:Clinical: most patients are euthyroidmost patients are euthyroid
MULTINODULAR GOITER MULTINODULAR GOITER =
= nodular enlarnodular enlargement, derivgement, derived from diffuse goiteed from diffuse goiterr
--both monoclonal & polyclonal nodulesboth monoclonal & polyclonal nodules
(adenomatous goiter) (adenomatous goiter) Clinical:
Clinical:
--most patients are euthyroidmost patients are euthyroid
--mass effects: compression of trachea, vessels &mass effects: compression of trachea, vessels &
nerves, & dysphagia nerves, & dysphagia
--hyperthyrhyperthyroidism oidism (toxic (toxic multinodular multinodular goiter)goiter)
--due to a hyperfunctioning noduledue to a hyperfunctioning nodule
--not accompanied by opthalmopathy ornot accompanied by opthalmopathy or dermopathy
dermopathy
* Morphology: massive enlar
* Morphology: massive enlargement (up to gement (up to >2000>2000 gm), nodules, with a
gm), nodules, with a mixture of hyperplastic &mixture of hyperplastic & dilated follicles, involutional
dilated follicles, involutional changes: hemorrhage,changes: hemorrhage, fibrosis,
THYROID NEOPLASMS THYROID NEOPLASMS -
- Solitary nodules Solitary nodules are are more more likely likely to be to be neoplastic.neoplastic. -
- Nodules Nodules in younger in younger patients patients (< 40 (< 40 years) years) & in& in males are more likely to be neoplastic.
males are more likely to be neoplastic. -
- Most Most neoplasms neoplasms (>90%) (>90%) are are benign benign (adenomas).(adenomas). -
- FunctiFunctioning (hot) oning (hot) nodules nodules on scion scintiscans ntiscans areare usually benign
usually benign
--Up to 10% oUp to 10% of cold nodules are malignantf cold nodules are malignant -
- Diagnosis Diagnosis can be can be made by made by fine neefine needle asdle aspirationpiration biopsy, or else by surgical excision biopsy.
biopsy, or else by surgical excision biopsy. THYROID ADENOMA
THYROID ADENOMA -
- adenomas accadenomas account for > 90% of ount for > 90% of thyroid tumorsthyroid tumors
--thyroid adenomas are not premalignantthyroid adenomas are not premalignant
Gross: a sharply demarcated solitary nodule Gross: a sharply demarcated solitary nodule Histology: a fibrous capsule separates the Histology: a fibrous capsule separates the neoplastic tissue from the surrounding neoplastic tissue from the surrounding
compressed gland. Patterns may be: trabecular compressed gland. Patterns may be: trabecular (embryonal), microfollicular (fetal)
(embryonal), microfollicular (fetal) macrofollimacrofollicularcular and Hurthle cell (oncocytic) adenomas
and Hurthle cell (oncocytic) adenomas -
- most most commonly commonly cold cold (nonfunctioning) (nonfunctioning) on on RI-scanRI-scan
--rarelrarely hot y hot (functioning) & may cause(functioning) & may cause
hyperthyroidism hyperthyroidism
THYROID CARCINOMA THYROID CARCINOMA -
- uncommon in uncommon in the US the US (~ 1.5% (~ 1.5% of all of all cancers).cancers). -
- major risk major risk facrtor is facrtor is exposure to exposure to radiationradiation Variants include:
Variants include: 1-
1- papillary papillary carcinoma carcinoma 80%80% 2-
2- follicular follicular carcinoma carcinoma 15%15% 3-
3- medullary medullary carcinoma carcinoma 5%5% 4-
4- anaplastic anaplastic carcinoma carcinoma rarerare PAPILLARY CARCINOMA
PAPILLARY CARCINOMA
--MC form of thyroid CaMC form of thyroid Ca
--Peak incidence: 3rd-5th decades, F > M.Peak incidence: 3rd-5th decades, F > M.
--Gene rearrangement on chromosome 10Gene rearrangement on chromosome 10
⇒
⇒
constitutive expre
constitutive expression of ssion of tyrosine kinase domain of tyrosine kinase domain of RET protooncogene
RET protooncogene
⇒
⇒
papillary thyroid carcinomapapillary thyroid carcinoma oncogene (RET/PTC)oncogene (RET/PTC) -
- Often Often multifocal, multifocal, spreads spreads to lymph to lymph nodes nodes in 50%in 50% of cases, but distant spread in only 5%.
of cases, but distant spread in only 5%. *
* Gross: unencapsulated,iGross: unencapsulated,infiltrative, often cysticnfiltrative, often cystic with foci of
with foci of fibrosis & calcification.fibrosis & calcification.
* Histology: papillary fronds, empty looking nuclei * Histology: papillary fronds, empty looking nuclei
“Orphan Annie eye”, nuclear grooves & “Orphan Annie eye”, nuclear grooves & psammoma bodies.
psammoma bodies.
* Variants: encapsulated, follicular, tall cell * Variants: encapsulated, follicular, tall cell * Prognosis: 90% survival at 20 years. * Prognosis: 90% survival at 20 years.
FOLLICULAR CARCINOMA FOLLICULAR CARCINOMA -
- peak peak incidence: incidence: 5th-6th 5th-6th decades, decades, F F > M.> M.
--incidence isincidence is
⇑
⇑
in areas of dietary iodine deficiencyin areas of dietary iodine deficiency* Gross: varies from well circumscribed to * Gross: varies from well circumscribed to
extensively invasive extensively invasive
* Histology: MC small uniform
* Histology: MC small uniform follicles containingfollicles containing colloid
colloid
with capsular and vascular invasion (sure sign of with capsular and vascular invasion (sure sign of malignancy).
malignancy).
* Variants: trabecular, Hurthle cell * Variants: trabecular, Hurthle cell
-
- spreads widely spreads widely to distant organs: to distant organs: bones, lungs,bones, lungs, liver, etc.
liver, etc.
- tumor tissue may
- tumor tissue may take up radioactive iodinetake up radioactive iodine
--patients often Rx’ed postop with patients often Rx’ed postop with thyroidthyroid
hormones to
hormones to
⇓
⇓
TSHTSH* Prognosis: depends on tumor stage, 25 to 45% * Prognosis: depends on tumor stage, 25 to 45%
10-yr survival rate for widely invasive tumors yr survival rate for widely invasive tumors
MEDULLARY CARCINOMA MEDULLARY CARCINOMA
-- NeurNeuroendoendocrinocrine tumor e tumor of C ceof C cells, lls, secrsecreteete calcitonin
calcitonin
--May May also secralso secrete: CEA, serete: CEA, serotoin, somatostatin, otoin, somatostatin, VIP,VIP,
ACTH, etc. ACTH, etc.
-- SporaSporadic or fadic or familimilial (aal (associssociated wated with MEith MEN IIa & IIbN IIa & IIb,, etc., in
etc., in
20% of cases) 20% of cases) -
- FFamilial cases are amilial cases are associated with germ lineassociated with germ line mutations in RET
mutations in RET * Gross:
* Gross: sporadic casessporadic cases: discrete tumor in one lobe,: discrete tumor in one lobe, peak incidence 5th-6th decades.
peak incidence 5th-6th decades. MEN-associated MEN-associated :: multicentric & bilateral , peak 3rd-4th decades multicentric & bilateral , peak 3rd-4th decades * Histology: cell nests or trabeculae, amyloid * Histology: cell nests or trabeculae, amyloid
deposits in the stroma, C cell
deposits in the stroma, C cell hyperplasihyperplasia, + a, + forfor calcitonin, chromograni
calcitonin, chromogranin, - n, - for thyroglobulinfor thyroglobulin * Prognosis: overall 5-yr survival rate is 60 to 80%, * Prognosis: overall 5-yr survival rate is 60 to 80%, survival rates are better in familial cases due to survival rates are better in familial cases due to screening programs, serum calcitonin & CEA screening programs, serum calcitonin & CEA levels are monitored post-op
levels are monitored post-op
-- TherThere are are usuae usually flly four glour glands (ands (they cthey can be aan be ass many as 12), weighting 30 to
many as 12), weighting 30 to 40 mg each,40 mg each,
situated in close proximity to the
situated in close proximity to the upper and lowerupper and lower poles of each thyroid lobe
poles of each thyroid lobe
-- HistHistologyology: compose: composed of chief ced of chief cells (thlls (the majore majority)ity) and fat cells. The chief cells may undergo
and fat cells. The chief cells may undergo transition to oxyphil cells (mitochondria), and transition to oxyphil cells (mitochondria), and water clear cells (glycogen).
water clear cells (glycogen). -- chichief cef cellells ss secrecrete ete PTHPTH
--secretisecretion of PTH on of PTH is regulated by the level of freeis regulated by the level of free
Ca Ca++++
--
⇑
⇑
PTH secretionPTH secretion⇒
⇒ ⇑
⇑
serum Ca++ by:serum Ca++ by:1. increasing synthesis of 1,25-(OH)2D, thus 1. increasing synthesis of 1,25-(OH)2D, thus enhancing
enhancing
absorption of calcium from GIT. absorption of calcium from GIT. 2. activating
2. activating osteoclastsosteoclasts
⇒
⇒
mobilizingmobilizing calcium from bonecalcium from bone
3. increasing renal tubular reabsorption of 3. increasing renal tubular reabsorption of calcium
calcium while while increasing increasing urinary urinary phosphatphosphatee excretion
excretion
--Causes of hypercalcemiaCauses of hypercalcemia::
--autonomous PTH autonomous PTH hypersecrhypersecretionetion
--osteolytic metastasesosteolytic metastases
--PTH-related protein (PTHrP)PTH-related protein (PTHrP)
PRIMARY HYPERPARATHYROIDISM PRIMARY HYPERPARATHYROIDISM =
= autonomous hypautonomous hypersecrersecretion of etion of PTH.PTH. -- AcAccoucounts fnts for up tor up to 90% oo 90% of casf cases of es of
hypercalcemia. hypercalcemia.
-- PePeak inak incidecidence 6tnce 6th decah decade & olde & older, der, F > M.F > M. -- Most cMost cases ases are are sporsporadicadic, but fe, but few casw cases ares aree
familial (associated with MEN I & MEN IIA) familial (associated with MEN I & MEN IIA) Causes: Causes: 1- Parathyroid adenoma (80%), 1- Parathyroid adenoma (80%), 2- Primary hyperplasia (15%), 2- Primary hyperplasia (15%), 3- Carcinoma (<5%) 3- Carcinoma (<5%) * Morphology: * Morphology:
••
Adenoma Adenoma--solitary & encapsulated, may consist of any of solitary & encapsulated, may consist of any of the 3 cell types
the 3 cell types
--remaining glands are normal toremaining glands are normal to
⇓
⇓
in sizein size PARATHYROID GLANDS
--may be in an ectopic locationmay be in an ectopic location
••
HyperplasiaHyperplasia--classically all 4 glands are involvedclassically all 4 glands are involved
--may be nodular or diffusemay be nodular or diffuse
••
CarcinomaCarcinoma--solitary, dense capsule, may exceed 10 gmsolitary, dense capsule, may exceed 10 gm
--cytologic features are not reliable, presence of cytologic features are not reliable, presence of invasion
invasion
or metastases required to make Dx or metastases required to make Dx * Clinical Features:
* Clinical Features: - asymptomatic - asymptomatic
-- 90% are asymptomatic & discovered on90% are asymptomatic & discovered on
routine
routine blood blood teststests
-- Ca++ & PTH levels areCa++ & PTH levels are
⇑
⇑
-- symptomaticsymptomatic
-- 10% are symptomatic10% are symptomatic
-- osteitis fibrosa cysticaosteitis fibrosa cystica
-- bone pain, pathologic Fx’sbone pain, pathologic Fx’s
--
⇑
⇑
bone resorption with bone resorption with expansilexpansilee areas (brown tumors)areas (brown tumors)
-- nephrolithiasisnephrolithiasis
-- metastatic metastatic calcificatcalcificationion
-- GI Sx’s: constipaton, nausea, peptic ulcers,GI Sx’s: constipaton, nausea, peptic ulcers,
pancreatitis pancreatitis
-- CNS Sx’s: depression, lethargy, seizuresCNS Sx’s: depression, lethargy, seizures
-- NM Sx’s: weakness, fatigueNM Sx’s: weakness, fatigue
SECONDARY HYPERPARATHYROIDISM SECONDARY HYPERPARATHYROIDISM =
= Compensatory hypCompensatory hypersecreersecretion of PTH due ttion of PTH due too hypocalcemia
hypocalcemia
--renal failurerenal failure
--vit. D deficiencyvit. D deficiency
* Morphology: * Morphology:
--hyperplasia of all (4) parathyroid glandshyperplasia of all (4) parathyroid glands
--skeletal skeletal changes of changes of “renal “renal osteodystosteodystrophy”rophy”
--metastatic calcificationmetastatic calcification
* Clinical: few
* Clinical: few cases develop “tertiary”cases develop “tertiary” hyperparathy
hyperparathyroidism, looks identical to roidism, looks identical to primaryprimary hyperplasia
hyperplasia
HYPOPARATHYROIDISM HYPOPARATHYROIDISM =
= PTH deficPTH deficiency & iency & hypocalcemiahypocalcemia
--neuromusculneuromuscular ar irritabiirritability lity (tetany): carpopedal(tetany): carpopedal
spasm, laryngospasm, mental status changes, spasm, laryngospasm, mental status changes, convulsions
convulsions
--cardiacardiac c conduction abnormalitiesconduction abnormalities
--calcificacalcification of tion of the eye lens (cataract)the eye lens (cataract)
--calcification of the basal ganglia (Parkinsonism),calcification of the basal ganglia (Parkinsonism),
⇑
⇑
ICP (headache & papilledema). ICP (headache & papilledema).
--MCC: surgical excisMCC: surgical excision of ion of all glands (during totalall glands (during total
thyroidectomy). thyroidectomy).
--LCC: congenital LCC: congenital parathyroiparathyroid d agenesis (DiGeorge’sagenesis (DiGeorge’s
syndrome), primary (idiopathic) atrophy syndrome), primary (idiopathic) atrophy -autoimmune damage
autoimmune damage
--Lab. data:Lab. data:
⇓
⇓
serum Caserum Ca++++&&⇓
⇓
serum PTH level.serum PTH level.PSEUDOHYPOPARA
PSEUDOHYPOPARATHYROIDISM
THYROIDISM (PHP)
(PHP)
== Hypocalcemia Hypocalcemia and hyperphand hyperphosphatemia, osphatemia, with:with:
--
⇑
⇑
serum levels of PTH with hyperplasia of theserum levels of PTH with hyperplasia of theparathyr
parathyroid oid glandsglands
--no osteitis fibrosa cysticano osteitis fibrosa cystica
--no vitamin D deficiency or renal failure.no vitamin D deficiency or renal failure.
* Pathogenesis: end-organ resistance to PTH, i.e. * Pathogenesis: end-organ resistance to PTH, i.e.
kidneys & bone do not respond to PTH kidneys & bone do not respond to PTH stimulation.
stimulation.
* Clinical Features: similar to hypoparathyroidism * Clinical Features: similar to hypoparathyroidism
(tetany, etc.) (tetany, etc.)
o
o PHP type 1 -PHP type 1 -
⇓
⇓
cyclic AMP response to PTHcyclic AMP response to PTH(deficiency
(deficiency of of GGssαα ) short stature, round) short stature, round
face, short neck, short metacarpals & face, short neck, short metacarpals & metatarsals (Albright hereditary metatarsals (Albright hereditary osteodystrophy).
osteodystrophy).
o
o PHP type PHP type 2 - 2 - normal cyclic AMP normal cyclic AMP response toresponse to
PTH, but with
PTH, but with
⇓
⇓
response to cyclic AMP,response to cyclic AMP, phenotypicallPSEUDOPSEUDOHYPOPARATHYROIDISM PSEUDOPSEUDOHYPOPARATHYROIDISM -
- In PHP In PHP type 1, type 1, other familother family members y members may emay exhibitxhibit the physical features of
the physical features of Albright hereditaryAlbright hereditary osteodystrophy (short stature, round face, short osteodystrophy (short stature, round face, short neck, short metacarpals & metatarsals) but are neck, short metacarpals & metatarsals) but are metabolically normal, with normal serum calcium metabolically normal, with normal serum calcium & normal PTH, i.e. false (pseudo)
& normal PTH, i.e. false (pseudo) pseudohypoparathyroidism. pseudohypoparathyroidism.
-- CompoComposed of twsed of two distio distinct uninct units: stets: steroid sroid secrecretingeting cortex
cortex & catech& catecholamine prolamine producing medullaoducing medulla -- In the In the adultadult, the n, the normaormal adrl adrenal enal weigweighs 4 gmhs 4 gm.. -- The coThe cortex crtex consisonsists of thrts of three funcee functionational zonesl zones::
1 - zona glomerulosa 1 - zona glomerulosa
2 - zona fasciculata (75% of the
2 - zona fasciculata (75% of the cortex)cortex) 3 -
3 - zona reticulariszona reticularis
-- The coThe cortex srtex secrecretes tetes threhree types oe types of sterf steroidoid hormones:
hormones: 1 -
1 - mineralocortimineralocorticoids (aldosterone) - zonacoids (aldosterone) - zona glomerulosa.
glomerulosa.
2 - glucocorticoids (cortisol) - zona 2 - glucocorticoids (cortisol) - zona fasciculata
fasciculata mainlymainly..
3 - sex steroids (testosterone) - zona 3 - sex steroids (testosterone) - zona reticularis
reticularis mainlymainly..
Cortisol Cortisol::
--regulateregulated by d by ACTH (& hypothalamic CRH)ACTH (& hypothalamic CRH)
--inhibits release of CRH & ACTHinhibits release of CRH & ACTH
--circulacirculates in the tes in the blood bound blood bound to plasma proteinsto plasma proteins
--free unbound cortisol is physiologically active &free unbound cortisol is physiologically active &
enters target cells by diffusion enters target cells by diffusion
--binds to binds to cytoplasmic receptorscytoplasmic receptors, then , then translocatedtranslocated
into the nucleus where it binds to into the nucleus where it binds to hormone-responsive elements
responsive elements altering expraltering expression of ession of specificspecific genes.
genes.
* Biologic effects: * Biologic effects:
--
⇑
⇑
gluconeogenesis &gluconeogenesis &⇓
⇓
uptake of glucose by fat &uptake of glucose by fat & musclemuscle
--
⇓
⇓
protein synthesis &protein synthesis &⇑
⇑
protein degradationprotein degradation--
⇑
⇑
vascular tone & vascular tone & some mineralocorticoidsome mineralocorticoid activityactivity
--anti-inflammatanti-inflammatory ory & immunosuppressive effects& immunosuppressive effects Aldosterone
Aldosterone:: -
- Accounts for Accounts for 95% 95% of of mineralocormineralocorticoid activityticoid activity..
--regulateregulated by d by renin-angrenin-angiotensin & iotensin & potassium levels.potassium levels.
--aldosteraldosterone promotes reabsorption of one promotes reabsorption of sodium andsodium and
excretion of potassium. excretion of potassium.
--excess aldosteroneexcess aldosterone
⇒
⇒
hypernatremia &hypernatremia &hypokalemia
hypokalemia
⇒
⇒
hyper-volemiahyper-volemia⇒
⇒
hypertension.hypertension. TestosteroneTestosterone::
--Excess testosterone in females causesExcess testosterone in females causes
defemenization & virilization; (hirsutism, acne, defemenization & virilization; (hirsutism, acne, amenorrhea, clitoral enlargement, atrophy of the amenorrhea, clitoral enlargement, atrophy of the breasts & uterus, deepening of the
breasts & uterus, deepening of the voice & frontalvoice & frontal balding).
balding).
ADRENAL GLAND
--In boys, excess testosterone leads to precociousIn boys, excess testosterone leads to precocious
puberty. puberty.
DISEASES OF ADRENAL CORTEX DISEASES OF ADRENAL CORTEX Hyperfunction
Hyperfunction (hyperadrena(hyperadrenalism):lism): -- CCuusshhiinngg’’s s ssyynnddrroommee -- HHyyppeerraallddoosstteerroonniissmm -- AAddrreennooggeenniittaal l ssyynnddrroommeess Hypofunction
Hypofunction (hypoadren(hypoadrenalism):alism):
-- AcAcute (e.g. ute (e.g. WWatatererhouhouse-se-FFririderderichichsesenn Syndrome)
Syndrome) -- CChhrroonniicc::
--primary (due to primary (due to adrenal corticaladrenal cortical insufficiency
insufficiency, , e.g. Addison’s e.g. Addison’s disease)disease)
--secondary (due to ACTH deficiency)secondary (due to ACTH deficiency)
--tertiary (rarely - due to hypothalamic CRHtertiary (rarely - due to hypothalamic CRH deficiency). deficiency). CUSHING’S SYNDROME CUSHING’S SYNDROME Etiology: Etiology:
1- Exogenous: high dose cortisone therapy (MCC). 1- Exogenous: high dose cortisone therapy (MCC). 2- Pituitary hypersecreti
2- Pituitary hypersecretion of on of ACTH (Cushing’sACTH (Cushing’s disease), accounts for 70% of
disease), accounts for 70% of endogenousendogenous hypercorti
hypercortisolism. solism. Associated Associated withwith hyperpigmentat
hyperpigmentation of the ion of the skin (skin (
↑
↑
MSH).MSH). 3- Autonomous hypersecretion of cortisol by 3- Autonomous hypersecretion of cortisol by ananadrenal adenoma, carcinoma or primary adrenal adenoma, carcinoma or primary hyperplasia (i.e. ACTH independent). hyperplasia (i.e. ACTH independent). 4- Ectopic production of ACTH or CRH by 4- Ectopic production of ACTH or CRH by
nonendocrine neoplasms (bronchogenic small cell nonendocrine neoplasms (bronchogenic small cell carcinoma).
carcinoma).
* Clinical features: truncal obesity, moon face, * Clinical features: truncal obesity, moon face, hirsutism, cutaneous striae, muscle
hirsutism, cutaneous striae, muscle weakness,weakness, osteoporosis, hypertension & hyperglycemia; osteoporosis, hypertension & hyperglycemia; Changes are reversible if the cause is corrected. Changes are reversible if the cause is corrected. * Morphology:
* Morphology:
•
•Cushing’s disease: ACTH is elevatedCushing’s disease: ACTH is elevated
⇒
⇒
adrenalsadrenalsare bilaterally hyperplastic. Changes are the are bilaterally hyperplastic. Changes are the same with ectopic ACTH or CRH.
same with ectopic ACTH or CRH.
•
•Adrenocortical neoplasms: uninvolved adrenalAdrenocortical neoplasms: uninvolved adrenal
cortex is usually atrophic due to
cortex is usually atrophic due to ACTHACTH suppression.
suppression. •
•Adenomas are small & cytologically blandAdenomas are small & cytologically bland appearing
appearing •
•Carcinomas are large & often anaplasticCarcinomas are large & often anaplastic
* Diagnosis: 24 hr
* Diagnosis: 24 hr urine free cortisol, plasma ACTH,urine free cortisol, plasma ACTH, Dexamethasone Suppression Test
Dexamethasone Suppression Test PRIMARY HYPERALDOSTERONISM PRIMARY HYPERALDOSTERONISM =
= excessive excessive secretion of secretion of aldosterone independentaldosterone independent of
of renin-angirenin-angiotensin system.otensin system.
* Features: hypervolemia, hypokalemia, * Features: hypervolemia, hypokalemia,
hypertension, low renin hypertension, low renin * Causes:
* Causes:
--MCC is MCC is aldosterone-aldosterone-secretinsecreting adenoma g adenoma (Conn’s(Conn’s
syndrome) in 80% of
syndrome) in 80% of casescases
--Bilateral idiopathic hyperplasia (? due to anBilateral idiopathic hyperplasia (? due to an
abnormal secretagogue) abnormal secretagogue)
--Glucorticoid-suppressible hyperaldosteronism:Glucorticoid-suppressible hyperaldosteronism:
hybrid cells produce both cortisol &
hybrid cells produce both cortisol & aldosterone,aldosterone,
⇑
⇑
aldosterone under influence of ACTH,aldosterone under influence of ACTH, suppressible by administration of suppressible by administration of dexamethasonedexamethasone
* Prognosis: adenomas are curable by surgery. * Prognosis: adenomas are curable by surgery. ADRENOGENIT
ADRENOGENITAL SAL SYNDROMESYNDROMES
Adrenogenital syndromes (ambiguous genitalia & Adrenogenital syndromes (ambiguous genitalia & virilism in females, and precocious puberty in virilism in females, and precocious puberty in males) can be caused by:
males) can be caused by:
1- Androgen-secreting adrenal cortical neoplasms. 1- Androgen-secreting adrenal cortical neoplasms. 2- Congenital Adrenal Hyperplasia (CAH):
2- Congenital Adrenal Hyperplasia (CAH):
--corticostercorticosteroid oid biosynthetic defectbiosynthetic defect
--MC 21-hydroxylase deficiency (90% of cases;MC 21-hydroxylase deficiency (90% of cases;
autosomal recessive)
autosomal recessive)
⇒
⇒ ⇓
⇓
cortisolcortisol⇒
⇒ ⇓
⇓
feedback inhibition of ACTHfeedback inhibition of ACTH
⇒
⇒ ⇑
⇑
ACTH levelsACTH levels⇒
⇒
bilateral adrenocortical hyperplasiabilateral adrenocortical hyperplasia
--aldosteraldosterone synthesis is MCly affected as one synthesis is MCly affected as wellwell
⇒
⇒
salt wasting salt wasting adrenogenadrenogenitalism (italism (⇓
⇓
NaNa++,,⇑
⇑
K K ++,,hypovolemia) hypovolemia)
ACUTE
ACUTE ADRENOCORTICAL ADRENOCORTICAL INSUFFICIENCY INSUFFICIENCY MCC is sudden withdrawal of
MCC is sudden withdrawal of corticostercorticosteroids inoids in cases of long-ter
cases of long-term steroid therm steroid therapy, or apy, or destructiondestruction of adrenals by massive hemorrhage
of adrenals by massive hemorrhage
Waterhouse-Friderichsen syndrome:
Waterhouse-Friderichsen syndrome:
--overwhelming meningococcal septicemiaoverwhelming meningococcal septicemia
--DIC with widespread purpura (esp. skin)DIC with widespread purpura (esp. skin)
--rapidly progressive hypotensionrapidly progressive hypotension
⇒
⇒
shockshock--massive bilat. adrenal hemorrhagemassive bilat. adrenal hemorrhage
⇒
⇒
acuteacuteadrenocorti
adrenocortical cal insufficiencyinsufficiency
--? causes of adrenal hemorrhage: DIC, endotoxin-? causes of adrenal hemorrhage: DIC,
endotoxin-induced vasculitis, bacterial seeding of induced vasculitis, bacterial seeding of smallsmall vessels
vessels
--high mortality ratehigh mortality rate
CHRONIC
CHRONIC ADRENOCORTICAL ADRENOCORTICAL INSUFFICIENCY INSUFFICIENCY * Primary (adrenal) or secondary
* Primary (adrenal) or secondary (hypothalamic/pituitary):
(hypothalamic/pituitary):
Primary (Addison’s disease):
Primary (Addison’s disease): MCC:MCC: autoimmune adrenalitis; tuberculosis, autoimmune adrenalitis; tuberculosis, metastatic cancers (
metastatic cancers (
⇒
⇒
destruction of destruction of≥≥
90% of 90% of the cortex)the cortex)
⇒
⇒
decreased cortisol & aldosterone,decreased cortisol & aldosterone, with feed-back elevation of ACTH (+with feed-back elevation of ACTH (+ MSH)MSH)
⇒
⇒
hyperpigmentathyperpigmentation of ion of skin,skin,
⇑
⇑
K K ++,,⇓
⇓
Na+,Na+,⇓
⇓
BP,BP,weakness, anorexia, N&V, hypoglycemia weakness, anorexia, N&V, hypoglycemia Secondary:
Secondary: to hypothalamic or pituitary lesionsto hypothalamic or pituitary lesions associated with decreased ACTH
associated with decreased ACTH
⇒
⇒
bilateralbilateral adrenal cortical atrophy, sparing the zona adrenal cortical atrophy, sparing the zona glomerulosa (skin color is pale andglomerulosa (skin color is pale and aldosteronealdosterone is normal, i.e. no sodium or potassium
is normal, i.e. no sodium or potassium abnormalities).
abnormalities). ADRENAL MEDULLA ADRENAL MEDULLA
--Composed of Composed of specializespecialized d neuroendocrneuroendocrineine
(chromaffin) cells, and is the major source of (chromaffin) cells, and is the major source of catecholamines: epinephrine & norepinephrine. catecholamines: epinephrine & norepinephrine.
--Chromaffin cells secrete catecholamines inChromaffin cells secrete catecholamines in
response to signals from preganglionic sympathetic response to signals from preganglionic sympathetic nerve fibers.
nerve fibers.
- These cells can also secrete a wide variety of These cells can also secrete a wide variety of bioactive amines and peptides, such as: histamine, bioactive amines and peptides, such as: histamine, serotonin, & neuropeptide hormones.
serotonin, & neuropeptide hormones.
--Clusters of similar neuroendocrine cells form theClusters of similar neuroendocrine cells form the
extra-adrenal paraganglia - closely associated with extra-adrenal paraganglia - closely associated with the autonomic nervous system.
the autonomic nervous system.
- The branchiomeric (carotid bodies) &
The branchiomeric (carotid bodies) & intravagalintravagal paraganglia are parasympathetic, and the
paraganglia are parasympathetic, and the aorticosympathetic (organs of Zuckerkandl) are aorticosympathetic (organs of Zuckerkandl) are sympathetic.
sympathetic.
PHEOCHROMOCYTOMA PHEOCHROMOCYTOMA =
= neoplasm composeneoplasm composed of chromaffid of chromaffin cells thatn cells that secretes catecholamines
secretes catecholamines (0.1 - (0.1 - 0.3 % 0.3 % of all of all cases of cases of hypertension) hypertension) * The “10 %” tumor: * The “10 %” tumor: • •10 % extra-adrenal10 % extra-adrenal • •10 % familial10 % familial • •10 % in children10 % in children •
•10 % bilateral in sporadic cases, but 70%10 % bilateral in sporadic cases, but 70% bilat.in familial cases
bilat.in familial cases •
•10 % malignant in adrenal cases, but up to 40%10 % malignant in adrenal cases, but up to 40% malignant in extra-adrenal cases
malignant in extra-adrenal cases * Clinical effects:
* Clinical effects: hypertension (paroxyshypertension (paroxysmal),mal), tachycardia,
tachycardia,
arrhythmias, tremors, sweating, sense of arrhythmias, tremors, sweating, sense of apprehension,
apprehension,
attacks can be fatal attacks can be fatal
* Diagnosis: 24 hour urine for catecholamines; or * Diagnosis: 24 hour urine for catecholamines; or
metanephrine
MUL
MULTIPLE ETIPLE ENDOCRINE NEOPLASIANDOCRINE NEOPLASIA:: MEN I (Wermer’s Syndrome
MEN I (Wermer’s Syndrome)) - heritable disorder cause
- heritable disorder caused by loss of d by loss of a tumora tumor suppres
suppressor gene on sor gene on chromosome 11.chromosome 11. 1.
1. Parathyroid Parathyroid hyperplasihyperplasia or a or adenoma (95%)adenoma (95%)
⇒
⇒ ⇑
⇑
CaCa++++
2.
2. PancreaticPancreatic Islet Cell tumors (75%)Islet Cell tumors (75%)
⇒
⇒
excessiveexcessive secretion of:secretion of: - gastrin
- gastrin
⇒
⇒
peptic ulcers (Zollinger-Ellisonpeptic ulcers (Zollinger-Ellison syndrome)syndrome) - insulin
- insulin
⇒
⇒
hypoglycemiahypoglycemia - serotonin- serotonin
⇒
⇒
carcinoid syndromecarcinoid syndrome - VIP- VIP
⇒
⇒
watery diarrheawatery diarrhea 3.3. Pituitary Pituitary adenoma (66%); MC adenoma (66%); MC prolactinomaprolactinoma,, also GH &
also GH & ACTH producing adenomasACTH producing adenomas MEN IIA (Sipple’s Syndrome)
MEN IIA (Sipple’s Syndrome)
-- inherited mutation iinherited mutation in the RET protooncogene n the RET protooncogene onon chromosome 10.
chromosome 10.
1. C cell hyperplasia or Medullary thyroid 1. C cell hyperplasia or Medullary thyroid
carcinoma (100%) carcinoma (100%)
2. Pheochromocytoma (50%), often bilateral and 2. Pheochromocytoma (50%), often bilateral and
may arise in the extra-adrenal paraganglia may arise in the extra-adrenal paraganglia 3. Parathyroid hyperplasia or adenoma (25%) 3. Parathyroid hyperplasia or adenoma (25%) MEN IIB (Gorlin’s Syndrome)
MEN IIB (Gorlin’s Syndrome)
--inherited mutation in the RET protooncogene oninherited mutation in the RET protooncogene on
chromosome 10, different from that seen in
chromosome 10, different from that seen in MEN IIAMEN IIA
--neoplasms are as in MEN IIA:neoplasms are as in MEN IIA:
1- C cell
1- C cell hyperplasia or Medullary thyroidhyperplasia or Medullary thyroid carcinoma (100 %)
carcinoma (100 %)
2- Pheochromocytoma (34%) 2- Pheochromocytoma (34%)
3- Parathyroid hyperplasia or adenoma (4%) 3- Parathyroid hyperplasia or adenoma (4%)
plus plus
4- Ganglioneuromas of the skin, eyes and 4- Ganglioneuromas of the skin, eyes and
mucous membranes of the mouth, GI tract, mucous membranes of the mouth, GI tract, respir
respiratory tract & atory tract & bladder (100%)bladder (100%) 5- Marfanoid body habitus (65%) 5- Marfanoid body habitus (65%)
---
-- Aanhin pa ang damo, Aanhin pa ang damo,
Kung sayo plang, may tama na ako? Kung sayo plang, may tama na ako? I list my number…. Can I
I list my number…. Can I have yours?have yours? Nagpapacute kba? Kc umeepekto eh! Nagpapacute kba? Kc umeepekto eh! Kulangot kba? Kasi I wanna take you Kulangot kba? Kasi I wanna take you out.out.
Hi, I’m yours, can I call you
Hi, I’m yours, can I call you mine?mine? --- galing sa old trans ng acute abdomen! just to --- galing sa old trans ng acute abdomen! just to have some good memories to remember about the have some good memories to remember about the exam. hehehe
exam. hehehe
LOVE is just a word until someone you meet gives it LOVE is just a word until someone you meet gives it a proper meaning